BELLICUM PHARMACEUTICALS, INC Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2022.
  • Bellicum Pharmaceuticals, Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $116K, a 83.1% decline year-over-year.
  • Bellicum Pharmaceuticals, Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $1.45M, a 47.5% decline year-over-year.
  • Bellicum Pharmaceuticals, Inc annual Share-based Payment Arrangement, Expense for 2022 was $2.61M, a 24.1% decline from 2021.
  • Bellicum Pharmaceuticals, Inc annual Share-based Payment Arrangement, Expense for 2021 was $3.44M, a 31.6% decline from 2020.
  • Bellicum Pharmaceuticals, Inc annual Share-based Payment Arrangement, Expense for 2020 was $5.03M, a 31.4% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.61M -$830K -24.1% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $3.44M -$1.59M -31.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $5.03M -$2.31M -31.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $7.34M -$6.49M -46.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $13.8M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.